BR100 Increased By (0.36%)
BR30 Decreased By (-0.13%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.37%)
AGHA 6.68 Increased By ▲ 0.01 (0.15%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 57.32 Increased By ▲ 0.88 (1.56%)
BOP 30.35 Increased By ▲ 0.01 (0.03%)
CNERGY 13.12 Increased By ▲ 0.03 (0.23%)
CSIL 5.41 Increased By ▲ 0.05 (0.93%)
FCCL 52.79 Increased By ▲ 0.41 (0.78%)
FFL 14.72 Decreased By ▼ -0.02 (-0.14%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 6.09 No Change ▼ 0.00 (0%)
KOSM 5.73 Increased By ▲ 0.77 (15.52%)
LOTCHEM 26.46 Decreased By ▼ -0.89 (-3.25%)
MLCF 93.16 Increased By ▲ 0.41 (0.44%)
NBP 164.66 Decreased By ▼ -0.32 (-0.19%)
NCPL 55.66 Increased By ▲ 0.02 (0.04%)
NPL 61.16 Decreased By ▼ -0.10 (-0.16%)
OGDC 316.73 Decreased By ▼ -1.03 (-0.32%)
PACE 9.87 Decreased By ▼ -0.06 (-0.6%)
PAEL 35.63 Increased By ▲ 0.13 (0.37%)
PIBTL 14.68 Increased By ▲ 0.11 (0.75%)
PPL 226.91 Decreased By ▼ -0.88 (-0.39%)
PRL 93.02 Increased By ▲ 0.45 (0.49%)
PTC 60.26 Decreased By ▼ -0.37 (-0.61%)
SSGC 23.81 Increased By ▲ 0.01 (0.04%)
TBL 8.75 Increased By ▲ 0.07 (0.81%)
TELE 7.80 Increased By ▲ 0.02 (0.26%)
TPL 22.35 Increased By ▲ 0.12 (0.54%)
TPLP 12.97 Increased By ▲ 0.30 (2.37%)
TREET 22.16 Decreased By ▼ -0.38 (-1.69%)
TRG 56.56 Decreased By ▼ -1.24 (-2.15%)

ISLAMABAD: The federal government has approved the Cannabis Control and Regulatory Authority (Licensing) Rules, 2026, paving the way for a regulated framework governing the cultivation, production, and commercial use of cannabis for medicinal and industrial purposes.

The rules, formulated by the Cannabis Control and Regulatory Authority (CCRA), were vetted by the Law and Justice Division and subsequently cleared by the Cabinet Committee for Disposal of Legislative Cases (CCLC), according to official sources.

The Cabinet Division informed the CCLC that the CCRA had been established under Section 3 of the Cannabis Control and Regulatory Authority Act, 2024. The authority is mandated to regulate the cultivation of cannabis plants, as well as the extraction, refining, manufacturing, and sale of cannabis derivatives intended for medicinal and industrial use.

Under Section 20 of the Act, no individual or entity is permitted to engage in the cultivation, production, manufacturing, product development, or sale of cannabis or its derivatives without obtaining a license from the Authority and complying with prescribed conditions.

Officials further stated that the draft Licensing Rules, 2026 were prepared by the CCRA with the approval of its Board and subsequently forwarded to the Law and Justice Division for vetting. The division endorsed the draft rules, subject to amendments, and recommended the deletion of Rules 23, 24, and 25 on the grounds that they either duplicated provisions already contained in the parent Act or conferred substantive powers that could not be included in subordinate legislation.

The revised draft, incorporating these amendments, was then presented to the CCLC for consideration.

The Cabinet Division also highlighted that Section 31 of the Act empowers the federal government to frame rules within six months of the Act’s commencement, on the recommendation of the Authority. These rules may cover a wide range of matters, including protocols for the disposal or destruction of illegal cannabis, policy guidelines, conditions governing import and export, and other ancillary matters necessary to implement the Act.

The law further requires that draft rules be published in the official Gazette to invite public feedback for a minimum period of 15 days. In compliance with this requirement, the draft Licensing Rules, 2026 were published through SRO 454(I)/2026 dated March 4, 2026. However, no public comments were received during the stipulated period.

Following this process, the Cabinet Division submitted the draft rules to the CCLC for final approval.

Copyright Business Recorder, 2026

Comments

200 characters remaining